From the Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX.
Clin Nucl Med. 2019 Feb;44(2):167-168. doi: 10.1097/RLU.0000000000002408.
An 80-year-old man with metastatic melanoma had been receiving treatment with pembrolizumab from September 2015 until June 2017. Series FDG PET/CT scans from March 7, 2017, to June 14, 2018, showed the course of biopsy-proven pembrolizumab-induced sarcoidosis. Reported here is the first case of multiorgan sarcoidosis induced by pembrolizumab and its self-resolving course on FDG PET/CT.
一位 80 岁男性患有转移性黑色素瘤，自 2015 年 9 月起接受 pembrolizumab 治疗，直至 2017 年 6 月。2017 年 3 月 7 日至 2018 年 6 月 14 日的 FDG PET/CT 扫描系列显示了经活检证实的 pembrolizumab 诱导的结节病的病程。本病例报告首例 pembrolizumab 诱导的多器官结节病及其在 FDG PET/CT 上的自行缓解过程。
